BEIJING SUMMIT CELL LIFE SCIENCE ENGINEERING RESEARCH INSTITUTE CO LTD

Overview

BEIJING SUMMIT CELL LIFE SCIENCE ENGINEERING RESEARCH INSTITUTE CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering HUMAN T CELL-DERIVED EXOSOMES; MSCS EXOSOMES POWDER.

API / Drug Master Files

BEIJING SUMMIT CELL LIFE SCIENCE ENGINEERING RESEARCH INSTITUTE CO LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• HUMAN T CELL-DERIVED EXOSOMESActive2024-11-27
• MSCS EXOSOMES POWDERActive2024-09-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BEIJING SUMMIT CELL LIFE SCIENCE ENGINEERING RESEARCH INSTITUTE CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.